| SB216763 |
ENSG00000117242.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000135253.9 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000146666.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000146666.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000167912.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000170919.11 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000173867.8 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000175701.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000176728.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000177993.3 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000179452.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000179818.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000180422.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000180846.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000181800.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000182376.2 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000182873.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000182873.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000184274.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000185904.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000186019.10 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000186594.8 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000187904.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000188660.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000189223.9 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000189419.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000196273.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000196756.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000196951.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000197210.7 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000197332.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000197670.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000198221.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000203258.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000203307.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000203307.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000203321.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000203362.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000203362.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000203496.4 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000203497.2 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000203706.4 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000203729.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000203808.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000203849.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000203875.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000203999.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000204054.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000204055.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000204272.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000204666.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000204802.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000204832.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000204949.4 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000205041.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000205611.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000206028.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000206142.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000206142.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000206195.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000206417.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000212663.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000213863.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000213971.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000214353.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000214559.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000214773.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000214851.4 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000214955.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000214955.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000215068.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000215244.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000215458.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000215498.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000215863.2 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000218018.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000223461.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000223477.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000223525.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000223685.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000223695.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000223704.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000223711.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000223734.2 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000223759.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000223759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000223759.2 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000223774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000223791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000223804.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000223809.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000223823.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000223831.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000223842.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000223855.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000223855.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000223882.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000224043.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000224043.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000224046.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000224049.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000224057.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000224063.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000224078.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000224078.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000224078.8 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000224093.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000224142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000224157.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000224228.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000224358.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000224363.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000224376.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000224413.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000224429.3 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000224460.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000224481.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000224505.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000224574.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000224577.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000224614.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000224616.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000224616.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000224635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000224691.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000224745.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000224805.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000224818.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000224821.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000224822.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000224822.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000224885.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000224939.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000224959.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000224977.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000224992.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000225039.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000225096.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000225111.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000225111.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000225113.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000225127.2 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000225138.3 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000225194.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000225205.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000225218.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000225235.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000225315.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000225361.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000225393.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000225434.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000225489.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000225493.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000225572.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000225572.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000225620.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000225655.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000225675.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000225684.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000225684.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000225750.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000225751.2 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000225767.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000225767.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000225783.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000225798.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000225798.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000225822.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000225882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000225889.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000225945.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000226007.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000226047.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000226067.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000226067.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000226091.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000226287.3 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000226383.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000226386.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000226416.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000226440.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000226445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000226453.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000226455.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000226578.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000226645.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000226648.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000226659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000226661.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000226684.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000226738.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000226754.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000226756.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000226828.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000226851.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000226883.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000226889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000226920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000227005.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000227028.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000227155.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000227215.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000227245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000227477.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000227495.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000227496.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000227512.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000227527.2 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000227533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000227544.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000227617.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000227617.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000227630.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000227630.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000227637.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000227673.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000227695.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000227741.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000227773.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000227811.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000227838.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000227857.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000227896.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000227908.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000228079.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000228079.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000228115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000228201.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000228237.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000228288.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000228372.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000228386.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000228393.3 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000228470.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000228486.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000228495.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000228540.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000228541.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000228604.3 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000228630.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000228661.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000228697.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000228741.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000228775.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000228791.3 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000228817.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000228857.2 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000228878.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000228886.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000228952.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000228972.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000228988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000229065.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000229109.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000229111.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000229118.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000229122.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000229127.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000229153.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000229190.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000229325.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000229325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000229348.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000229388.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000229444.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000229463.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000229487.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000229521.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000229531.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000229582.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000229587.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000229645.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000229646.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000229656.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000229697.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000229739.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000229766.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000229801.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000229841.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000229869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000229896.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000229950.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000229999.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000230024.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000230054.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000230061.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000230065.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000230082.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000230176.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000230177.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000230290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000230310.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000230319.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000230438.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000230438.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000230454.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000230461.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000230490.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000230498.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000230498.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000230499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000230550.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000230606.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000230633.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000230790.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000230839.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000230925.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000230937.5 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000231050.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000231104.4 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000231131.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000231185.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000231187.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000231188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000231272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000231273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000231290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000231305.3 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000231367.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000231460.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000231512.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000231528.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000231528.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000231528.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000231563.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000231599.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000231611.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000231628.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000231691.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000231768.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000231829.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000231840.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000231856.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000231877.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000231903.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000231943.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000231966.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000231969.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000231971.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000232093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000232098.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000232151.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000232192.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000232194.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000232284.3 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000232295.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000232310.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000232316.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000232347.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000232352.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000232377.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000232377.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000232406.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000232412.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000232533.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000232536.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000232545.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000232586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000232611.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000232613.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000232642.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000232645.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000232648.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000232648.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000232656.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000232677.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000232692.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000232692.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000232693.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000232827.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000232828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000232855.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000232874.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000232931.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000232977.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000233016.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000233029.3 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000233067.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000233068.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000233077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000233081.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000233081.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000233081.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000233178.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000233237.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000233242.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000233332.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000233339.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000233368.2 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000233396.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000233461.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000233496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000233515.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000233554.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000233593.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000233651.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000233661.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000233672.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000233757.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000233844.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000233844.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000233852.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000233885.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000233885.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000233967.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000234006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000234070.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000234072.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000234134.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000234134.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000234134.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000234141.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000234141.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000234155.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000234160.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000234233.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000234350.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000234352.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000234361.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000234456.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000234459.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000234503.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000234614.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000234690.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000234718.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000234789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000234793.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000234807.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000234817.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000234818.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000234869.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000234915.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000234943.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000234978.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000234998.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000235026.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000235029.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000235052.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000235066.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000235072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000235079.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000235100.3 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000235117.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000235117.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000235246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000235262.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000235262.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000235298.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000235319.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000235398.4 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000235427.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000235461.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000235501.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000235621.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000235641.3 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000235652.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000235659.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000235664.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000235751.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000235760.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000235790.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000235802.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000235802.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000235820.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000235852.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000235872.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000235872.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000235999.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000235999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000236003.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000236017.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000236051.2 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000236081.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000236095.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000236255.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000236305.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000236324.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000236337.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000236358.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000236364.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000236366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000236383.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000236404.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000236426.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000236514.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000236519.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000236537.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000236546.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000236581.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000236682.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000236711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000236778.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000236824.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000236842.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000236869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000236871.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000236901.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000236924.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000236935.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000236943.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000236953.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000236953.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000236977.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000237017.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000237017.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000237407.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000237463.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000237481.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000237502.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000237505.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000237505.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000237520.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000237523.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000237548.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000237576.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000237594.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000237605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000237646.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000237658.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000237705.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000237742.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000237750.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000237807.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000237813.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000237886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000237976.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000238005.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000238005.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000238033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000238057.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000238123.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000238140.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000238184.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000238250.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000238273.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000238282.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000239002.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000239353.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000239569.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000239636.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000239674.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000239920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000240032.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000240057.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000240254.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000240790.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000241014.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000241125.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000241313.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000241481.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000241886.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000242094.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000242136.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000242258.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000242540.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000242553.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000242578.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000242759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000242770.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000243926.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000243967.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000244184.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000244184.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000244198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000244265.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000244268.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000244342.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000244459.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000244479.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000244541.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000244676.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000244676.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000244791.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000245060.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000245293.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000245330.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000245466.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000245468.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000245479.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000245522.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000245552.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000245910.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000246145.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000246145.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000246273.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000246273.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000246640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000246740.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000246763.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000246851.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000246982.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000247081.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000247081.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000247092.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000247131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000247134.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000247157.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000247271.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000247372.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000247416.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000247556.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000247679.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000247844.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000247934.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000248112.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000248115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000248175.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000248243.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000248254.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000248265.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000248416.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000248445.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000248476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000248599.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000248599.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000248671.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000248758.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000248758.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000248774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000248774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000248846.2 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000248858.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000248936.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000248936.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000249028.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000249042.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000249412.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000249412.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000249412.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000249502.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000249526.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000249592.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000249593.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000249602.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000249628.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000249655.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000249664.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000249673.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000249740.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000249791.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000249825.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000249870.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000249870.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000249906.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000249911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000249996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000250081.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000250101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000250116.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000250122.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000250155.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000250156.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000250237.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000250241.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000250451.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000250508.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000250602.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000250635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000250659.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000250734.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000250740.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000250786.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000250846.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000250899.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000250903.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000250909.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000250958.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000250990.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000251009.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000251031.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000251054.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000251131.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000251151.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000251191.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000251259.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000251331.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000251365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000251396.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000251405.2 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000251580.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000251602.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000251602.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000251675.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000251675.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000253116.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000253133.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000253167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000253168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000253171.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000253263.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000253343.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000253372.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000253372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000253374.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000253392.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000253438.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000253477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000253477.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000253552.3 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000253582.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000253586.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000253603.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000253636.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000253649.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000253688.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000253706.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000253799.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000253837.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000253859.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000253878.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000254039.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000254162.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000254165.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000254208.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000254219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000254235.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000254237.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000254266.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000254286.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000254340.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000254389.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000254428.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000254432.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000254433.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000254468.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000254468.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000254468.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000254477.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000254477.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000254484.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000254510.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000254510.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000254528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000254538.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000254560.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000254577.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000254615.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000254620.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000254631.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000254687.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000254718.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000254910.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000254985.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000254987.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000254990.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000254991.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000255008.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000255031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000255142.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000255142.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000255158.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000255158.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000255159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000255165.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000255234.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000255248.2 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000255250.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000255250.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000255274.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000255308.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000255318.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000255321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000255345.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000255362.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000255372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000255409.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000255410.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000255435.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000255471.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000255495.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000255517.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000255521.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000255539.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000255557.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000255571.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000255670.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000255741.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000255760.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000255867.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000255916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000256006.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000256011.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000256020.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000256050.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000256116.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000256139.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000256195.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000256237.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000256299.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000256360.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000256442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000256442.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000256443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000256458.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000256508.2 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000256542.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000256546.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000256564.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000256588.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000256609.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000256705.3 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000256712.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000256712.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000256746.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000256746.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000256789.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000256802.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000256894.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000256897.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000256897.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000256955.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000257023.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000257038.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000257038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000257058.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000257058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000257058.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000257083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000257135.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000257151.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000257176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000257226.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000257226.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000257261.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000257264.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000257270.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000257283.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000257298.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000257475.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000257527.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000257534.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000257543.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000257568.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000257613.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000257636.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000257640.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000257642.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000257647.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000257647.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000257660.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000257671.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000257809.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000257894.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000257964.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000258082.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000258334.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000258355.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000258424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000258424.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000258450.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000258457.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000258520.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000258553.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000258556.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000258623.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000258701.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000258711.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000258717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000258730.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000258736.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000258752.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000258754.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000258789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000258811.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000258851.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000258858.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000258891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000258897.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000258935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000258940.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000258952.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000258959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000259067.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000259088.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000259118.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000259138.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000259182.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000259198.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000259230.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000259245.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000259287.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000259287.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000259349.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000259359.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000259364.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000259372.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000259398.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000259408.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000259416.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000259422.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000259432.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000259437.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000259447.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000259463.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000259475.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000259515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000259515.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000259520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000259548.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000259583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000259583.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000259598.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000259606.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000259618.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000259635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000259656.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000259659.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000259701.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000259712.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000259713.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000259714.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000259725.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000259732.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000259758.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000259762.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000259771.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000259775.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000259797.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000259818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000259840.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000259915.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000259921.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000259953.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000259967.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000259969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000259974.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000260006.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000260011.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000260018.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000260063.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000260084.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000260086.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000260095.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000260101.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000260123.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000260192.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000260205.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000260269.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000260269.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000260269.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000260269.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000260278.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000260302.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000260317.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000260336.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000260367.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000260400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000260404.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000260411.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000260430.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000260441.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000260441.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000260441.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000260466.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000260509.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000260555.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000260577.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000260583.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000260589.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000260591.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000260597.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000260597.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000260630.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000260633.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000260657.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000260661.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000260672.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000260693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000260711.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000260725.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000260743.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000260773.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000260790.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000260792.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000260803.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000260834.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000260837.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000260855.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000260871.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000260874.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000260877.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000260877.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000260905.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000260910.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000260920.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000260930.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000260953.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000260979.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000260988.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000260988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000260989.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000261040.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000261040.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000261043.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000261064.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000261069.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000261069.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000261069.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000261098.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000261104.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000261105.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000261158.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000261159.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000261172.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000261191.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000261195.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000261207.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000261220.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000261242.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000261253.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000261280.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000261293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000261302.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000261372.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000261390.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000261394.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000261404.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000261416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000261431.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000261437.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000261437.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000261438.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000261442.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000261447.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000261447.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000261455.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000261468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000261481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000261529.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000261533.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000261542.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000261543.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000261572.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000261589.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000261592.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000261597.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000261662.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000261663.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000261670.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000261670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000261673.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000261690.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000261713.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000261766.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000261770.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000261770.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000261798.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000261821.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000261839.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000261864.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000262155.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000262222.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000262222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000262223.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000262265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000262652.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000262668.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000262678.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000262721.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000262837.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000262873.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000262966.2 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000263013.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000263013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000263214.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000263220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000263307.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000263316.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000263350.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000263393.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000263499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000263657.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000263916.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000263924.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000264012.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000264083.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000264107.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000264107.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000264151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000264188.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000264188.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000264222.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000264270.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000264365.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000264421.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000264448.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000264458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000264520.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000264812.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000264895.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000264924.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000264940.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000264956.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000264964.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000264964.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000265185.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000265222.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000265222.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000265342.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000265349.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000265443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000265445.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000265494.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000265750.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000265800.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000265888.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000265907.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000266010.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000266040.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000266088.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000266176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000266236.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000266278.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000266371.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000266538.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000266844.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000266904.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000266908.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000266912.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000266923.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000266926.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000266933.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000266935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000266936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000266941.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000266957.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000266965.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000266969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000266970.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000266975.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000266975.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000266987.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000266993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000266999.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000266999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267034.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267044.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000267044.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000267053.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000267082.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000267136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267152.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000267163.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000267172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267191.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000267194.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000267194.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267196.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267219.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000267221.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000267244.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000267244.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000267248.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000267249.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000267255.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000267255.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000267273.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000267277.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000267279.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000267282.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000267284.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267288.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000267289.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000267302.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000267306.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267342.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000267344.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000267348.2 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000267366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267388.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000267419.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000267439.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000267454.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000267479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267481.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000267539.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000267563.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267565.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000267579.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000267582.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000267588.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000267613.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000267613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267627.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000267637.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000267649.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000267677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267715.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000267730.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000267743.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267745.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000267750.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000267776.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000267858.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000267886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000267904.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000267905.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000267905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000267919.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000267919.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000267940.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000267986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000268015.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000268047.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000268047.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000268061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000268093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000268204.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000268205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000268333.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000268340.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000268416.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000268655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000268670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000268833.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000268912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000269054.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000269107.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000269148.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000269172.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000269386.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000269386.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000269427.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000269473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000269481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000269489.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000269524.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000269640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000269653.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000269867.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000269893.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000269895.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000269938.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000269947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000269966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000269974.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000270006.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000270048.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000270052.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000270055.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000270060.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000270061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000270068.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000270072.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000270081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000270104.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000270177.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000270195.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000270246.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000270246.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000270482.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000270599.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000270599.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000270640.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000270673.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000270704.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000270704.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000270720.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000270761.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000270828.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000271127.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000271133.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000271200.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000271327.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000271344.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000271347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000271347.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000271359.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000271553.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000271590.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000271659.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000271738.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000271755.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000271788.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000271789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000271830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000271833.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000271845.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000271856.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000271882.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000271916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000271967.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000271978.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000271991.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000271993.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000272004.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000272029.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000272029.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000272033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000272081.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000272088.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000272097.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000272102.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000272102.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000272112.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000272137.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000272143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000272172.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000272172.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000272192.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000272198.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000272205.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000272226.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000272254.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000272282.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000272308.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000272316.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000272361.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000272369.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000272373.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000272402.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000272432.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000272440.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000272446.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000272463.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000272465.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000272506.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000272520.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000272542.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000272544.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000272556.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000272562.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000272562.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000272567.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000272604.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000272635.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000272657.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000272657.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| SB216763 |
ENSG00000272659.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000272662.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000272662.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000272699.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000272720.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000272732.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000272734.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000272744.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000272746.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000272755.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000272777.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000272791.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000272795.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000272800.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000272827.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000272829.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000272846.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000272846.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000272848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000272858.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000272861.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000272864.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000272871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000272888.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000272933.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000272953.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000272960.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000272979.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000273001.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000273001.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000273014.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| SB216763 |
ENSG00000273014.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000273015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000273017.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000273017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000273027.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000273033.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000273066.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000273097.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000273102.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000273113.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000273118.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000273203.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000273209.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000273243.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000273247.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000273281.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000273281.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| SB216763 |
ENSG00000273287.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000273305.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000273319.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000273329.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000273352.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000273356.1 |
Predicted lncRNA |
Esophageal cancer |
|
| SB216763 |
ENSG00000273367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000273372.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000273384.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| SB216763 |
ENSG00000273384.1 |
Predicted lncRNA |
Sarcoma |
|
| SB216763 |
ENSG00000273442.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| SB216763 |
ENSG00000273443.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| SB216763 |
ENSG00000273445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| SB216763 |
ENSG00000273472.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| SB216763 |
ENSG00000273473.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| SB216763 |
ENSG00000273492.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|